ALT US EQUITY Health Care Biotechnology & Medical CIK: 1326190

Altimmune, Inc. (ALT) Quant Factor Diagnostic & Fair Value Model

Altimmune, Inc. (Ticker: ALT) is listed in the Health Care sector (Biotechnology & Medical). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$2.12
-2.30% Latest Close (2026-10-23)
Market Cap: $2.56M
P/E Ratio: -
Momentum Strength 3M / 12M
0.00%
1M: -30.26% 12M: 0.00%
Quality (ROE) Point-in-Time
-
Trailing Return on Equity
Technical Trend RSI 14
18.4
SMA50: $2.72 SMA200: $2.72
Valuation Multiplier Trailing
-
Pre-Profit / Negative TTM
📊 Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM

ALT has negative or near-zero trailing GAAP earnings over the trailing twelve months.

⚡ Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线多头 (MA20/50) Piotroski F-Score: 0/9 (Under Pressure or Early Stage Growth)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1326190 · 10-K 年报 / 10-Q 季报
Form Period End Filing Timestamp (Point-in-Time) Revenue Net Income Operating CF EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1326190

💡 Methodology & Frequently Asked Questions

Key reference details regarding Altimmune, Inc. (ALT) valuation multiples, momentum factors, and point-in-time filing conventions.

How should ALT's current valuation multiple be interpreted? ↓
ALT trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are ALT's key momentum and technical factor indicators? ↓
As of the latest close, ALT shows a 1-month return of -30.26%, 3-month return of 0.00%, and 12-month return of 0.00%, with a 14-day RSI of 18.4. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for ALT? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can ALT be incorporated into systematic factor models? ↓
ALT can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.

Related Peers & Valuation Comparison in Health Care

Dense Internal Network Mesh